{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05399654",
            "orgStudyIdInfo": {
                "id": "INCLINE-101"
            },
            "organization": {
                "fullName": "Tallac Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors",
            "officialTitle": "A Phase 1/2, Open Label, Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors",
            "acronym": "INCLINE-101",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-dose-escalation-and-expansion-study-of-tac-in-patients-with-select-advanced-or-metastatic-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-06-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01-27",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-05-19",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-19",
            "studyFirstSubmitQcDate": "2022-05-26",
            "studyFirstPostDateStruct": {
                "date": "2022-06-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Tallac Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "INCLINE-101 is an open label, multicenter Phase 1/2 study designed to evaluate safety, pharmacokinetics (PK), and preliminary anti-tumor activity of TAC-001 administered intravenously."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced or Metastatic Solid Tumors"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "TAC-001 Single-Agent Dose-Escalation Cohorts",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: TAC-001"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "TAC-001",
                    "description": "TAC-001 is a Toll-like Receptor Agonist Antibody Conjugate (TRAAC)",
                    "armGroupLabels": [
                        "TAC-001 Single-Agent Dose-Escalation Cohorts"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Dose-Escalation Stage: RP2D for TAC-001",
                    "description": "To identify the recommended dose phase 2 dose (RP2D) for further evaluation of TAC-001 when administered as monotherapy in subjects with advanced or metastatic solid tumors",
                    "timeFrame": "2-years"
                },
                {
                    "measure": "Dose Expansion: Characterization of ORR for TAC-001",
                    "description": "To evaluate preliminary efficacy of TAC-001 by estimating the overall response rate (ORR; combined complete response \\[CR\\] and partial response \\[PR\\]) as assessed by the Investigator per RECIST 1.1 and iRECIST",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Dose Expansion: Characterization of duration of response for TAC-001",
                    "description": "To evaluate preliminary efficacy of TAC-001 by estimating the duration of response as assessed by the Investigator per RECIST 1.1 and iRECIST",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Dose Expansion: Characterization of clinical benefit rate for TAC-001",
                    "description": "To evaluate preliminary efficacy of TAC-001 by estimating the clinical benefit rate as assessed by the Investigator per RECIST 1.1 and iRECIST",
                    "timeFrame": "2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence and Severity of Nonserious Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                    "description": "To evaluate the safety of TAC-001 monotherapy through the evaluation of incidence and severity of nonserious AEs and SAEs, including immune-related adverse events (irAEs), as graded by investigators according to CTCAE version 5.0",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Maximum Plasma Concentration (Cmax)",
                    "description": "To evaluate the Cmax of TAC-001 monotherapy",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Maximum Plasma Concentration (Tmax)",
                    "description": "To evaluate the Tmax of TAC-001 monotherapy",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Area Under the Plasma Concentration-Time Curve (AUC)",
                    "description": "To evaluate the AUC of TAC-001 monotherapy",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Terminal Half-Life",
                    "description": "To evaluate the terminal half-life of TAC-001 monotherapy",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Clearance of TAC-001",
                    "description": "To evaluate the drug clearance of TAC-001 monotherapy",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Evaluation of immunogenicity of TAC-001",
                    "description": "Incidence of antidrug antibodies (ADA) against TAC-001",
                    "timeFrame": "2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Histologically or cytologically-documented solid tumors.\n2. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1.\n3. Demonstrate adequate organ function.\n\nExclusion Criteria:\n\n1. Prior history of or active malignant disease other than that being treated in this study.\n2. Known brain metastases or cranial epidural disease.\n3. A known hypersensitivity to the components of the study therapy or its' analogs.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kevin Heller, MD",
                    "role": "CONTACT",
                    "phone": "(650) 866-1966",
                    "email": "tac-001safety@tallactx.com"
                },
                {
                    "name": "Colleen Oliver",
                    "role": "CONTACT",
                    "email": "Colleen@Tallactx.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Southern California (USC)",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anthony El-Khoueiry, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of Colorado",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sunnie Kim, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute (SCRI)- Denver",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jason Henry, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "AdventHealth Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32804",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Guru Sonpavde, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute (SCRI)- Florida Cancer Specialists and Research Institute, LLC",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32827",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cesar Perez, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "John Theurer Cancer Center",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Martin Guiterrez, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "Weill Cornell Medicine- NYU Clinical Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dominique Leone",
                            "role": "CONTACT",
                            "email": "dol4002@med.cornell.edu"
                        },
                        {
                            "name": "Anna Pavlick, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "West Cancer Center & Research Institute",
                    "status": "RECRUITING",
                    "city": "Germantown",
                    "state": "Tennessee",
                    "zip": "38138",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Daniel Vaena, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.08676,
                        "lon": -89.81009
                    }
                },
                {
                    "facility": "The University of Texas MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarina Piha-Paul, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "NEXT Oncology",
                    "status": "RECRUITING",
                    "city": "Irving",
                    "state": "Texas",
                    "zip": "75039",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shiraj Sen, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.81402,
                        "lon": -96.94889
                    }
                },
                {
                    "facility": "NEXT Oncology- Virginia",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexander Spira, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Clinical Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Nedlands",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -31.98184,
                        "lon": 115.8073
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M16974",
                    "name": "Triamcinolone",
                    "relevance": "LOW"
                },
                {
                    "id": "M16975",
                    "name": "Triamcinolone Acetonide",
                    "relevance": "LOW"
                },
                {
                    "id": "M237966",
                    "name": "Triamcinolone hexacetonide",
                    "relevance": "LOW"
                },
                {
                    "id": "M209573",
                    "name": "Triamcinolone diacetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                }
            ]
        }
    },
    "hasResults": false
}